National Institute of Health The Cancer Genome Atlas National Cancer Institute National Human Genome Research Institute
Home > Publications > Integrated Molecular Characterization of Uterine Carcinosarcoma, 2017

Integrated Molecular Characterization of Uterine Carcinosarcoma

Cancer Cell, Volume 31, Issue 3, p411–423, 13 March 2017



We performed genomic, epigenomic, transcriptomic and proteomic characterizations of uterine carcinosarcomas (UCSs). Cohort samples had extensive copy number alterations and highly recurrent somatic mutations. Frequent mutations were found in TP53, PTEN, PIK3CA, PPP2R1A, FBXW7 and KRAS, similar to endometrioid and serous uterine carcinomas. Transcriptome sequencing identified a strong epithelial-to-mesenchymal transition (EMT) gene signature in a subset of cases that was attributable to epigenetic alterations at microRNA promoters. The range of EMT scores in UCS was the largest amongst all tumor types studied via The Cancer Genome Atlas. UCSs shared proteomic features with gynecologic carcinomas and sarcomas with intermediate EMT features. Multiple somatic mutations and copy number alterations in genes that are therapeutic targets were identified.

Supplementary Data Files

Views of the Data

TCGA Data Portal

Associated Data Files

These data represent a data freeze from FREEZE DATE HERE. Please note that more recent data are available via the TCGA Data Portal.

The data are supported by different organizations. All data marked by [DCC] are DCC-validated archives. All data marked by [Supplementary] were created by the manuscript authors and you should contact the corresponding author for support.

Participant List, Sample List, BAM File List, and Full Listing of TCGA Archives for Data Freeze


Microsatellite Instability


Reverse Phase Protein Array (RPPA) Expression

RNA Expression from IlluminaHiseq RNASeq

SNP and Copy Number variation from Affymetrix SNP6

miRNA from Illumina HiSeq 2000

Methylation from Illumina Infinium Human Methylation450

Additional Information